Trexquant Investment’s Organogenesis Holdings ORGO Stock Holding History

Trexquant Investment’s Portfolio ORGO Stock Details ORGO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	–	Sell	-149,107	Closed	-$772K	–	1979
2025 Q4	$772K	Buy	+149,107	New	+$722K	0.01%	1255
2025 Q2	–	Sell	-119,359	Closed	-$516K	–	1781
2025 Q1	$516K	Buy	+119,359	New	+$482K	0.01%	1267
2022 Q3	–	Sell	-152,749	Closed	-$745K	–	1727
2022 Q2	$745K	Sell	152,749 -10,006	-6%	-$61.6K	0.03%	642
2022 Q1	$1.24M	Buy	162,755 +147,750	+985%	+$1.14M	0.06%	400
2021 Q4	$139K	Buy	+15,005	New	+$159K	0.01%	1204

Other funds holding ORGO

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

SCM

Soleus Capital Management Greenwich, Connecticut $2.47B AUM 115.63% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

FLAM

First Light Asset Management Edina, Minnesota $1.12B AUM 114.45% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return

Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.57% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Deutsche Bank Frankfurt Am Main Ge, Germany $303B AUM 30.15% 1-Year Est. Return

Trexquant Investment's ORGO Position: Q1 2026 in Review

Trexquant Investment sold out of Organogenesis Holdings (ORGO) in Q1 2026, closing a stake of 149,107 shares — an estimated $772K sold.

Trexquant Investment first reported a position in ORGO in Q4 2021 and held it in 5 quarters. The position peaked at $1.24M in Q1 2022. 121 funds tracked by Wall St. Rank hold ORGO as of Q1 2026.

Trexquant Investment reported no remaining Organogenesis Holdings position as of Q1 2026 after selling out during the quarter.
Trexquant Investment sold 149,107 Organogenesis Holdings shares in Q1 2026, an estimated $772K.
Trexquant Investment first reported a position in Organogenesis Holdings in Q4 2021 and held it in 5 quarters.
Trexquant Investment's Organogenesis Holdings position peaked at $1.24M in Q1 2022.
121 funds tracked by Wall St. Rank held Organogenesis Holdings as of Q1 2026.

Based on Trexquant Investment's 13F filing for Q1 2026, filed 15 May 2026.